232 related articles for article (PubMed ID: 33674398)
1. PSMA- and GRPR-Targeted PET: Results from 50 Patients with Biochemically Recurrent Prostate Cancer.
Baratto L; Song H; Duan H; Hatami N; Bagshaw HP; Buyyounouski M; Hancock S; Shah S; Srinivas S; Swift P; Moradi F; Davidzon G; Iagaru A
J Nucl Med; 2021 Nov; 62(11):1545-1549. PubMed ID: 33674398
[TBL] [Abstract][Full Text] [Related]
2. A Pilot Study of
Duan H; Ghanouni P; Daniel B; Rosenberg J; Thong A; Kunder C; Aparici CM; Davidzon GA; Moradi F; Sonn GA; Iagaru A
J Nucl Med; 2023 May; 64(5):744-750. PubMed ID: 36396456
[TBL] [Abstract][Full Text] [Related]
3. A Pilot Study of
Duan H; Ghanouni P; Daniel B; Rosenberg J; Davidzon GA; Aparici CM; Kunder C; Sonn GA; Iagaru A
J Nucl Med; 2023 Apr; 64(4):592-597. PubMed ID: 36328488
[TBL] [Abstract][Full Text] [Related]
4. Correlation of
Duan H; Baratto L; Fan RE; Soerensen SJC; Liang T; Chung BI; Thong AEC; Gill H; Kunder C; Stoyanova T; Rusu M; Loening AM; Ghanouni P; Davidzon GA; Moradi F; Sonn GA; Iagaru A
J Nucl Med; 2022 Dec; 63(12):1829-1835. PubMed ID: 35552245
[No Abstract] [Full Text] [Related]
5. Diagnosis of recurrent prostate cancer with PET/CT imaging using the gastrin-releasing peptide receptor antagonist
Wieser G; Popp I; Christian Rischke H; Drendel V; Grosu AL; Bartholomä M; Weber WA; Mansi R; Wetterauer U; Schultze-Seemann W; Meyer PT; Jilg CA
Eur J Nucl Med Mol Imaging; 2017 Aug; 44(9):1463-1472. PubMed ID: 28417160
[TBL] [Abstract][Full Text] [Related]
6. Prospective Evaluation of
Minamimoto R; Sonni I; Hancock S; Vasanawala S; Loening A; Gambhir SS; Iagaru A
J Nucl Med; 2018 May; 59(5):803-808. PubMed ID: 29084827
[No Abstract] [Full Text] [Related]
7. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
8. Pilot Comparison of ⁶⁸Ga-RM2 PET and ⁶⁸Ga-PSMA-11 PET in Patients with Biochemically Recurrent Prostate Cancer.
Minamimoto R; Hancock S; Schneider B; Chin FT; Jamali M; Loening A; Vasanawala S; Gambhir SS; Iagaru A
J Nucl Med; 2016 Apr; 57(4):557-62. PubMed ID: 26659347
[TBL] [Abstract][Full Text] [Related]
9.
Duan H; Moradi F; Davidzon GA; Liang T; Song H; Loening AM; Vasanawala S; Srinivas S; Brooks JD; Hancock S; Iagaru A
Lancet Oncol; 2024 Apr; 25(4):501-508. PubMed ID: 38423030
[TBL] [Abstract][Full Text] [Related]
10. PET Imaging Using Gallium-68 (
Duan H; Iagaru A
PET Clin; 2022 Oct; 17(4):621-629. PubMed ID: 36153233
[TBL] [Abstract][Full Text] [Related]
11. Prospective Evaluation of
Song H; Harrison C; Duan H; Guja K; Hatami N; Franc BL; Moradi F; Aparici CM; Davidzon GA; Iagaru A
J Nucl Med; 2020 Apr; 61(4):546-551. PubMed ID: 31628216
[No Abstract] [Full Text] [Related]
12. Prospective Study of the Radiolabeled GRPR Antagonist BAY86-7548 for Positron Emission Tomography/Computed Tomography Imaging of Newly Diagnosed Prostate Cancer.
Touijer KA; Michaud L; Alvarez HAV; Gopalan A; Kossatz S; Gonen M; Beattie B; Sandler I; Lyaschenko S; Eastham JA; Scardino PT; Hricak H; Weber WA
Eur Urol Oncol; 2019 Mar; 2(2):166-173. PubMed ID: 31017093
[TBL] [Abstract][Full Text] [Related]
13. Comparison of [(18)F]DCFPyL and [ (68)Ga]Ga-PSMA-HBED-CC for PSMA-PET Imaging in Patients with Relapsed Prostate Cancer.
Dietlein M; Kobe C; Kuhnert G; Stockter S; Fischer T; Schomäcker K; Schmidt M; Dietlein F; Zlatopolskiy BD; Krapf P; Richarz R; Neubauer S; Drzezga A; Neumaier B
Mol Imaging Biol; 2015 Aug; 17(4):575-84. PubMed ID: 26013479
[TBL] [Abstract][Full Text] [Related]
14. Early lesion detection with
Wondergem M; Jansen BHE; van der Zant FM; van der Sluis TM; Knol RJJ; van Kalmthout LWM; Hoekstra OS; van Moorselaar RJA; Oprea-Lager DE; Vis AN
Eur J Nucl Med Mol Imaging; 2019 Aug; 46(9):1911-1918. PubMed ID: 31230088
[TBL] [Abstract][Full Text] [Related]
15. The Clinical Utility of
Nakamoto R; Harrison C; Song H; Guja KE; Hatami N; Nguyen J; Moradi F; Franc BL; Aparici CM; Davidzon G; Iagaru A
Mol Imaging Biol; 2021 Aug; 23(4):614-623. PubMed ID: 33469884
[TBL] [Abstract][Full Text] [Related]
16. Higher Preoperative Maximum Standardised Uptake Values (SUV
de Bie KCC; Veerman H; Bodar YJL; Meijer D; van Leeuwen PJ; van der Poel HG; Donswijk ML; Vis AN; Oprea-Lager DE
Diagnostics (Basel); 2023 Jul; 13(14):. PubMed ID: 37510087
[TBL] [Abstract][Full Text] [Related]
17. Reduced Acquisition Time per Bed Position for PET/MRI Using
Duan H; Baratto L; Hatami N; Liang T; Levin CS; Khalighi MM; Iagaru A
AJR Am J Roentgenol; 2022 Feb; 218(2):333-340. PubMed ID: 34406051
[No Abstract] [Full Text] [Related]
18. PSA-Stratified Performance of
Dietlein F; Kobe C; Neubauer S; Schmidt M; Stockter S; Fischer T; Schomäcker K; Heidenreich A; Zlatopolskiy BD; Neumaier B; Drzezga A; Dietlein M
J Nucl Med; 2017 Jun; 58(6):947-952. PubMed ID: 27908968
[TBL] [Abstract][Full Text] [Related]
19. Voxel-based comparison of [
Fassbender TF; Schiller F; Zamboglou C; Drendel V; Kiefer S; Jilg CA; Grosu AL; Mix M
EJNMMI Res; 2020 Jun; 10(1):62. PubMed ID: 32533273
[TBL] [Abstract][Full Text] [Related]
20. Modified PROMISE criteria for standardized interpretation of gastrin-releasing peptide receptor (GRPR)-targeted PET.
Duan H; Davidzon GA; Moradi F; Liang T; Song H; Iagaru A
Eur J Nucl Med Mol Imaging; 2023 Nov; 50(13):4087-4095. PubMed ID: 37555901
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
